Skip to content

Clinical trials

Phase 3 Skin Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Neoplasms Phase: Phase 3 Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20132
20172
20181
20201
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Pfizer2
Regeneron Pharmaceuticals2
Agenus Inc.1
Genta Incorporated1
Idera Pharmaceuticals, Inc.1
Iovance Biotherapeutics, Inc.1
Melanoma and Skin Cancer Trials Limited1
Nektar Therapeutics1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Neoplasms14
Melanoma11
Neoplasm Metastasis3
Neoplasms2
Skin Diseases2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.